To investigate the role of telomerase inhibition on AFP secretion, we treated cells belonging to the hepatocellular carcinoma cell lines HepG2/C3A and PLC/PRF/5 with two different telomerase inhibitors, namely costunolide and BIBR1532. Here, AFP is linked to hepatocellular carcinoma.